Top

CardioVascular and Interventional Radiology

Published in:

01-01-2009 | Clinical Investigation

CT-Guided Radiofrequency Ablation in Patients with Hepatic Metastases from Breast Cancer

Authors: Tobias F. Jakobs, Ralf-Thorsten Hoffmann, Angelika Schrader, Hans Joachim Stemmler, Christoph Trumm, Andreas Lubienski, Ravi Murthy, Thomas K. Helmberger, Maximilian F. Reiser

Published in: CardioVascular and Interventional Radiology | Issue 1/2009

Abstract

The purpose of this study was to evaluate technical success, technique effectiveness, and survival following radiofrequency ablation for breast cancer liver metastases and to determine prognostic factors. Forty-three patients with 111 breast cancer liver metastases underwent CT-guided percutaneous radiofrequency (RF) ablation. Technical success and technique effectiveness was evaluated by performing serial CT scans. We assessed the prognostic value of hormone receptor status, overexpression of human epidermal growth factor receptor 2 (HER2), and presence of extrahepatic tumor spread. Survival rates were calculated using the Kaplan–Meier method. Technical success was achieved in 107 metastases (96%). Primary technique effectiveness was 96%. During follow-up local tumor progression was observed in 15 metastases, representing a secondary technique effectiveness of 86.5%. The overall time to progression to the liver was 10.5 months. The estimated overall median survival was 58.6 months. There was no significant difference in terms of survival probability with respect to hormone receptor status, HER2 overexpression, and presence of isolated bone metastases. Survival was significantly lower among patients with extrahepatic disease, with the exception of skeletal metastases. We conclude that CT-guided RF ablation of liver metastases from breast cancer can be performed with a high degree of technical success and technique effectiveness, providing promising survival rates in patients with no visceral extrahepatic disease. Solitary bone metastases did not negatively affect survival probability after RF ablation.

Jardines L, Callans LS, Torosian MH (1993) Recurrent breast cancer: presentation, diagnosis, and treatment. Semin Oncol 20(5):538–547PubMed

Gregory WM, Smith P, Richards MA et al (1993) Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer 68(5):988–995PubMed

Miller KD, Sledge GW Jr (1999) The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am 13(2):415–434PubMedCrossRef

Stockler M, Wilcken NR, Ghersi D et al (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26(3):151–168PubMedCrossRef

Hoe AL, Royle GT, Taylor I (1991) Breast liver metastases—incidence, diagnosis and outcome. J R Soc Med 84(12):714–716PubMed

Zinser JW, Hortobagyi GN, Buzdar AU et al (1987) Clinical course of breast cancer patients with liver metastases. J Clin Oncol 5(5):773–782PubMed

Adam R, Aloia T, Krissat J et al (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897–907PubMedCrossRef

Carlini M, Lonardo MT, Carboni F et al (2002) Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology 49(48):1597–1601PubMed

Maksan SM, Lehnert T, Bastert G et al (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 26(3):209–212PubMedCrossRef

10.

Raab R, Nussbaum KT, Behrend M et al (1998) Liver metastases of breast cancer: results of liver resection. Anticancer Res 18(3C):2231–2233PubMed

11.

Selzner M, Morse MA, Vredenburgh JJ et al (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127(4):383–389PubMedCrossRef

12.

Vlastos G, Smith DL, Singletary SE et al (2004) Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11(9):869–874PubMedCrossRef

13.

Konecny GE, Thomssen C, Luck HJ et al (2004) Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. J Natl Cancer Inst 96(15):1141–1151PubMedCrossRef

14.

Imkampe A, Bendall S, Bates T (2007) The significance of the site of recurrence to subsequent breast cancer survival. Eur J Surg Oncol 33(4):420–423PubMedCrossRef

15.

Goldberg SN, Gazelle GS, Compton CC et al (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88(11):2452–2463PubMedCrossRef

16.

Paulet E, Aube C, Pessaux P et al (2008) Factors limiting complete tumor ablation by radiofrequency ablation. CardioVasc Interv Radiol 31(1):107–115CrossRef

17.

Rahman ZU, Frye DK, Smith TL et al (1999) Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference. Cancer 85(1):104–111PubMedCrossRef

18.

Bergh J, Jonsson PE, Glimelius B et al (2001) A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 40(2–3):253–281PubMedCrossRef

19.

Cristofanilli M, Hortobagyi GN (2001) New horizons in treating metastatic disease. Clin Breast Cancer 1(4):276–287PubMedCrossRef

20.

O’Reilly SM, Richards MA, Rubens RD (1990) Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 26(5):574–577PubMed

21.

Jakobs TF, Hoffmann RT, Trumm C et al (2006) Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 26(1B):671–680PubMed

22.

Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39(11):689–697PubMedCrossRef

23.

Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3):961–967PubMedCrossRef

24.

Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210(3):655–661PubMed

25.

Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214(3):761–768PubMed

26.

Livraghi T, Solbiati L, Meloni F et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 97(12):3027–3035PubMedCrossRef

27.

Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66PubMedCrossRef

28.

Lawes D, Chopada A, Gillams A et al (2006) Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl 88(7):639–642PubMedCrossRef

29.

Livraghi T, Goldberg SN, Solbiati L et al (2001) Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 220(1):145–149PubMed

30.

Gunabushanam G, Sharma S, Thulkar S et al (2007) Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. J Vasc Interv Radiol 18(1; Pt 1):67–72PubMedCrossRef

31.

Lencioni R (2004) Tumor Radiofrequency Ablation Italian Network (TRAIN): survival analysis in breast cancer patients with isolated hepatic metastases. 2004 Assembly of the Radiological Society of North America, Chicago, IL

32.

Hortobagyi GN, Smith TL, Legha SS et al (1983) Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1(12):776–786PubMed

33.

Perez JE, Machiavelli M, Leone BA et al (1990) Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. Grupo Oncologico Cooperativo del Sur. Am J Clin Oncol 13(4):294–298PubMedCrossRef

34.

Leone BA, Romero A, Rabinovich MG et al (1988) Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis. The GOCS (Grupo Oncologico Cooperativo del Sur) experience. Am J Clin Oncol 11(6):618–622PubMedCrossRef

35.

Muss HB (1992) Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res Treat 21(1):15–26PubMedCrossRef

36.

Rowlings PA, Williams SF, Antman KH et al (1999) Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA 282(14):1335–1343PubMedCrossRef

37.

Rizzieri DA, Vredenburgh JJ, Jones R et al (1999) Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol 17(10):3064–3074PubMed

38.

Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy—local tumor control rate and survival data. Radiology 233:400PubMedCrossRef

39.

Adam R, Aloia T, Krissat J et al (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897–908PubMedCrossRef

Title: CT-Guided Radiofrequency Ablation in Patients with Hepatic Metastases from Breast Cancer
Authors: Tobias F. Jakobs
Ralf-Thorsten Hoffmann
Angelika Schrader
Hans Joachim Stemmler
Christoph Trumm
Andreas Lubienski
Ravi Murthy
Thomas K. Helmberger
Maximilian F. Reiser
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 1/2009
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-008-9384-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CT-Guided Radiofrequency Ablation in Patients with Hepatic Metastases from Breast Cancer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Angiographic Evaluation of Carotid Artery Grafting with Prefabricated Small-Diameter, Small-Intestinal Submucosa Grafts in Sheep

Migration of Embolization Coils: Our Experience

Three-Dimensional Rotational Angiography of the Inferior Vena Cava as an Adjunct to Inferior Vena Cava Filter Retrieval

Failure and Success of Percutaneous Angioplasty in a Hypertensive Child with Bilateral Renal Artery Stenosis

An Unusual Left Ventricular Outflow Pseudoaneurysm: Usefulness of Echocardiography and Multidetector Computed Tomography for Surgical Repair

Patient Dose Reference Levels for Interventional Radiology: A National Approach